Subcutaneous octreotide for the prevention of early variceal rebleeding.
DeLédinghen
V
V
Ripault
M P
MP
Silvain
C
C
Beauchant
M
M
Raffoux
N
N
Bouquet
S
S
D004932:Esophageal and Gastric Varices / Q000150:complications*; D005765:Gastrointestinal Agents / Q000493:pharmacokinetics*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D015282:Octreotide / Q000008:administration & dosage / Q000493:pharmacokinetics*; D012008:Recurrence
D005765:Gastrointestinal Agents; D015282:Octreotide